ABIRATERONE Drug Patent Profile
✉ Email this page to a colleague
When do Abiraterone patents expire, and what generic alternatives are available?
Abiraterone is a drug marketed by Amneal Pharms, Apotex, Dr Reddys, Florida, Glenmark Speclt, Hikma, MSN, Mylan, Novugen, Qilu, Rising, Teva Pharms Usa, and Wockhardt Bio Ag. and is included in fifteen NDAs.
The generic ingredient in ABIRATERONE is abiraterone acetate. There are twenty-five drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the abiraterone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Abiraterone
A generic version of ABIRATERONE was approved as abiraterone acetate by APOTEX on October 31st, 2018.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ABIRATERONE?
- What are the global sales for ABIRATERONE?
- What is Average Wholesale Price for ABIRATERONE?
Summary for ABIRATERONE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for ABIRATERONE |
| DailyMed Link: | ABIRATERONE at DailyMed |
US Patents and Regulatory Information for ABIRATERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208327-001 | Jan 7, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208371-001 | Feb 25, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Speclt | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 209227-001 | Oct 16, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208416-001 | May 18, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208446-001 | Oct 31, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
